HEAD Study
Start date:1st August 2019 End date:
31st August 2019 Co-ordinated by:
Julia Grahamslaw
Prospective multicentre observational study conducted over one calendar month in 2019, with a planned sample size of 1000 over 5 sites. The aim of the study was to describe the epidemiology of non-trauma related headache in adults presenting to emergency departments including investigations, treatments and outcome.
This includes adult patients presenting to the ED with non-trauma-related headache as their primary complaint.
This was a study working in collaboration with the Trainee Emergency Medicine Research Network (TERN) to understand the international epidemiology of patients presenting to the ED with a headache.
Research Team
Julia Grahamslaw
Lead Research Nurse
Dr Matt Reed
Director of EMERGE, Consultant, NRS Career Research Fellow & Honorary Reader in Emergency Medicine
Sian Dalgleish
Senior Research Nurse
More EMERGE Trials
TARGET CTCA is a joint venture between EMERGE and the cardiology research team aiming to recruit patients with suspected ACS across NHS Lothian and NHS Greater Glasgow and Clyde. The study aims to recruit 2270 participants. For further information, please contact the EMERGE team.
TARGET-CTCA Trial
ISARIC4C – Coronavirus Clinical Characterisation Consortium, an observational study
ISARIC/WHO Clinical Characterisation Protocol for Severe Emerging Infections in the UK (CCP-UK)
DASH Trial
DASH is a randomised clinical trial investigating a treatment to reverse the effects of blood-thinning medications.